Advanced

Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Janson, Eva Tiensuu; Sorbye, Halfdan; Welin, Staffan; Federspiel, Birgitte; Gronbaek, Henning; Hellman, Per; Ladekarl, Morten; Langer, Seppo W.; Mortensen, Jann and Schalin-Jantti, Camilla, et al. (2014) In Acta Oncologica 53(10). p.1284-1297
Abstract
Background. The diagnostic work-up and treatment of patients with neuroendocrine neoplasms (NENs) has undergone major recent advances and new methods are currently introduced into the clinic. An update of the WHO classification has resulted in a new nomenclature dividing NENs into neuroendocrine tumours (NETs) including G1 (Ki67 index <= 2%) and G2 (Ki67 index 3-20%) tumours and neuroendocrine carcinomas (NECs) with Ki67 index > 20%, G3. Aim. These Nordic guidelines summarise the Nordic Neuroendocrine Tumour Group's current view on how to diagnose and treat NEN-patients and are meant to be useful in the daily practice for clinicians handling these patients.
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Acta Oncologica
volume
53
issue
10
pages
1284 - 1297
publisher
Taylor & Francis
external identifiers
  • wos:000344005600003
  • scopus:84911929619
ISSN
1651-226X
DOI
10.3109/0284186X.2014.941999
language
English
LU publication?
yes
id
8c399b94-01a9-4ed1-96ca-384a0055fdea (old id 4875679)
date added to LUP
2015-01-07 10:27:38
date last changed
2017-11-19 03:58:09
@article{8c399b94-01a9-4ed1-96ca-384a0055fdea,
  abstract     = {Background. The diagnostic work-up and treatment of patients with neuroendocrine neoplasms (NENs) has undergone major recent advances and new methods are currently introduced into the clinic. An update of the WHO classification has resulted in a new nomenclature dividing NENs into neuroendocrine tumours (NETs) including G1 (Ki67 index &lt;= 2%) and G2 (Ki67 index 3-20%) tumours and neuroendocrine carcinomas (NECs) with Ki67 index &gt; 20%, G3. Aim. These Nordic guidelines summarise the Nordic Neuroendocrine Tumour Group's current view on how to diagnose and treat NEN-patients and are meant to be useful in the daily practice for clinicians handling these patients.},
  author       = {Janson, Eva Tiensuu and Sorbye, Halfdan and Welin, Staffan and Federspiel, Birgitte and Gronbaek, Henning and Hellman, Per and Ladekarl, Morten and Langer, Seppo W. and Mortensen, Jann and Schalin-Jantti, Camilla and Sundin, Anders and Sundlöv, Anna and Thiis-Evensen, Espen and Knigge, Ulrich},
  issn         = {1651-226X},
  language     = {eng},
  number       = {10},
  pages        = {1284--1297},
  publisher    = {Taylor & Francis},
  series       = {Acta Oncologica},
  title        = {Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms},
  url          = {http://dx.doi.org/10.3109/0284186X.2014.941999},
  volume       = {53},
  year         = {2014},
}